The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Scientists find green way to turn CO2 into fuel with sunlight

  • 3

    BLACKPINK's contract renewal still in limbo

  • 5

    Family of 5 found dead in 3 separate locations

  • 7

    Kim Jong-un's rejection of Russia's food assistance irritates North Korean defectors

  • 9

    INTERVIEWVirtual K-pop group MAVE: is more than just pretty pixels

  • 11

    Korea boosts subsidies to rev up falling EV sales

  • 13

    All-Korean showdowns set up on 1st day of medal race

  • 15

    Disney+ aims to expand investment in original Korean content

  • 17

    Hebrew University students travel to Korea to explore musical landscape

  • 19

    Appellate court upholds 9-yr prison term for man over filming, distributing sexual videos featuring women

  • 2

    N. Korea holds politburo meeting to discuss Kim-Putin summit: KCNA

  • 4

    BTS member Suga begins mandatory military service

  • 6

    Xi says he will seriously consider visit to South Korea: official

  • 8

    Opposition party in turmoil as leader could be arrested on Tuesday

  • 10

    Foreign employees rewarded for contribution to Korea's shipbuilding industry

  • 12

    Russia lodges protest to S.Korean envoy over Yoon's UN speech

  • 14

    Lawmakers want to grill business tycoons over decision to rejoin FKI

  • 16

    Arrest warrant hearing for DPK leader Lee to be held Tuesday

  • 18

    Yoon signs off on plan to waive expressway tolls during Chuseok holiday

  • 20

    Gov't reviews changing description of Fukushima wastewater

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
World
  • SCMP
  • Asia
Sun, September 24, 2023 | 20:59
SCMP
How China quietly grew into 'cannabis superpower'
Posted : 2017-08-29 10:33
Updated : 2017-08-29 10:27
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
A farmer in Sunwu county, Heilongjiang province, harvests a crop of cannabis plants.
A farmer in Sunwu county, Heilongjiang province, harvests a crop of cannabis plants.

By Stephen Chen

A farmer in Sunwu county, Heilongjiang province, harvests a crop of cannabis plants.
Every year in April, Jiang Xingquan sets aside part of his farm in northern China to grow cannabis. The size of the plot varies with market demand but over the last few years it has been about 600 hectares.

Like every other hemp farmer in Hexin in Heilongjiang province near the Russian border, Jiang is growing the plant legally.

The growers sell the stems of the crop to textile factories to make high-quality fabric, the leaves to pharmaceutical companies for drugs, and the seeds to food companies to make snacks, kitchen oil and drinks.

For the farmers, the crop is green gold – hemp brings in more than 10,000 yuan (US$1,500) per hectare, compared to just a few thousand yuan for more common crops like corn. It also has few natural enemies so there's little need for expensive pesticides.

"That's pure profit," Jiang said.

Jiang's farm is in China's frosty north and is one of the country's major centres for the legal crop. Authorities in the province turned a blind eye to its production before legalising and regulating it last year. Another major growing area is in Yunnan province where the plant's production has been regulated since 2003.

Together, these areas account for about half of the world's legal commercial cropland under hemp cannabis cultivation, according to the National Bureau of Statistics.

Thanks to government support and a long tradition, China has quietly become a superpower in the plant's production and research.

There are no official figures for the amount of the plant China produces each year but plantations are flourishing – both for commercial and illicit drug use.

This growth has in part been made possible by government-funded scientists who study the plant's military uses, including as medication and fabric for uniforms.

Over the decades, researchers developed various hybrid species that not just survived but thrived in China's disparate environments, from the Arctic conditions in Heilongjiang, to Inner Mongolia's Gobi Desert to the subtropics of Yunnan.

In 2014, the Ministry of Public Security said it found a large number of unregistered hemp and marijuana plantations across the nation, particularly in Jilin and Inner Mongolia.

Hemp cannabis is one variety of the Cannabis sativa plant, which also includes types better known as marijuana. The difference between the two is the amount of the psychoactive component THC, with hemp varieties containing just trace amounts of it.

Both the hemp and marijuana strains of the plant also contain cannabidiol, or CBD, a compound that has been used to treat a wide range of conditions such as epilepsy and Parkinson's disease.

Cannabis sativa has been cultivated in China for centuries, mainly for the plant's strong fibres which can be turned into rope, fabric and paper. Hemp fabric dating back more than 3,400 years has been found in Shang Dynasty tombs in Hebei, and the fibre is believed to have been the basis of the earliest forms of paper made in the country.

Other parts of the plant, such as seeds and leaves, have been used in Chinese traditional medicine – but with warnings of side effects.

The Divine Farmer's Classic of Materia Medica, a pharmaceutical text complied in the first or second century AD, warns: "A person will see a ghost after an overdose, [and] run around like mad ... After moderate long-term intake, [he or she] will be able to communicate to God."

After the establishment of the People's Republic, the Communist Party-led government classified the plant as an illicit drug and introduced some of the world's toughest rules against its production, trade and consumption.

Anybody with more than 5kg of processed marijuana leaves, 10kg of resin, or 150kg of fresh leaves can face the death penalty, under Chinese criminal law.

Despite the tough laws, authorities have usually turned a blind eye to farmers growing their own low-THC varieties because they were an important source of income for some farmers. Farmers have largely been spared in drug crackdowns but in some areas such as Xinjiang bans on the crop – even the low-THC trypes – have been strictly enforced, due to concerns about drug abuse in the region.

Research into the plant really took off in China in the late 1970s when the country went to war with Vietnam, according to some scientists.

The military needed to develop a fabric that could keep soldiers clean and dry in Vietnam's humidity, and cannabis hemp offered the fibre that breathed and was antibacterial. Other studies explored the plant's use as a drug in field hospitals.

As a result of that research, more than half of the world's 600-plus patents related to the plant are now held in China, according to the World Intellectual Property Organisation. This has prompted concerns in the Western pharmaceutical industry that the Chinese government or Chinese firms might take advantage of the patent barriers.

On market analysis site InvestorIntel, Dr Luc Duchesne, an Ottawa-based businessman and biochemist, said: "Because cannabis in Western medicine is becoming accepted, the predominance of Chinese patents suggests that pharmaceutical sciences are evolving quickly in China, outpacing Western capabilities.

"[Chinese traditional medicine] is poised to take advantage of a growing trend. The writing is on the wall: westernised Chinese traditional medicine is coming to a dispensary near you."

Yang Ming, the head scientist of China's Cannabis sativa research programme at the Institute of Industrial Crops at the Yunnan Academy of Agricultural Sciences, said many farmers who used to grow flax in the province had quickly made the leap to hemp cannabis, thanks to the much higher returns.

But just how many farmers or how much land was devoted to the crop was a national secret.

"It's a big figure. It cannot be revealed to the public. Many farms are, strictly speaking, illegal under current law and regulations," he said.

To start growing the crop, farmers need a special licence and so far they're restricted to growers in Heilongjiang and Yunnan.

"In other provinces [hemp] farmers might plant varieties with THC levels higher than 0.3 per cent, an internationally accepted benchmark beyond which it is considered unsafe," Yang said.

The central government last year considered issuing regulations to outlaw these farms but dropped the idea because there were so many of them and the move could trigger massive protests by farmers, he said.

Yun Chunming, professor with the Institute of Bast Fibre Crops at the Chinese Academy of Agricultural Sciences in Hunan, said the legality issue would remain a major challenge to the Cannabis sativa boom in China.

"We have seen the growing enthusiasm of farmers, and they are indeed planting low-THC varieties. But cannabis is cannabis. However low the THC concentration, massive plantations can increase the risk of drug abuse and lead to many social problems," he said, suggesting that the THC could be concentrated if enough of the crop were grown.

Tan Xin, president of Beijing-based Hemp Investment Group, one of the largest Chinese companies advocating the commercial pharmaceutical use of the plant, said the company had partnered with the People's Liberation Army to take the Chinese technology and product to the world.

A drug to treat traumatic stress disorder jointly developed by the company and the Chinese military was nearing completion of clinical trials, and it was just one of the many products from the plant with global market potential, according to a statement on the company's website.

"We expect the sector will grow into a 100 billion yuan industry for China in five years' time," he said.

With offices in the United States and plans to branch out into Canada, Israel, Japan and Europe, Tang said the company was taking the plant to all member countries in China's "Belt and Road Initiative", an infrastructure scheme to link China with the rest of Asia and beyond.

Back in Heilongjiang, Jiang said he and family had tasted the vegetable oil made from hemp seeds.

"It has a very strong fragrance and tastes good, but we felt dizzy after dinner," he said.

"We dare not try it very often."

 
miguel
Top 10 Stories
1Understanding Korean Modernization Understanding Korean Modernization
2Bears of Joseon part 1: Fanciful tales and deadly claws Bears of Joseon part 1: Fanciful tales and deadly claws
3Exhibition for soldiers highlights North Korea's human rights abuses Exhibition for soldiers highlights North Korea's human rights abuses
4Sil-A overcomes stage fright, and them some Sil-A overcomes stage fright, and them some
5Korea, Saudi Arabia celebrate 93rd Saudi National Day, vow stronger cooperation Korea, Saudi Arabia celebrate 93rd Saudi National Day, vow stronger cooperation
6Bears of Joseon part 2: Behind bars Bears of Joseon part 2: Behind bars
7JTI Korea joins Jongno clean-up JTI Korea joins Jongno clean-up
8Mirae Asset Global Investments' AUM reaches $219 bil. Mirae Asset Global Investments' AUM reaches $219 bil.
9Samsung, SK relieved by revised chip restrictions on ChinaSamsung, SK relieved by revised chip restrictions on China
10CKD Kochon Foundation awards Ukraine health authorities for treating tuberculosis patients amid raging war CKD Kochon Foundation awards Ukraine health authorities for treating tuberculosis patients amid raging war
Top 5 Entertainment News
1TEMPEST gears up to showcase fiery passion TEMPEST gears up to showcase fiery passion
2[INTERVIEW] Yim Si-wan went extra mile to portray legendary athlete in 'Road to Boston' INTERVIEWYim Si-wan went extra mile to portray legendary athlete in 'Road to Boston'
3BLACKPINK's contract renewal still in limbo BLACKPINK's contract renewal still in limbo
4[INTERVIEW] Virtual K-pop group MAVE: is more than just pretty pixels INTERVIEWVirtual K-pop group MAVE: is more than just pretty pixels
5Hebrew University students travel to Korea to explore musical landscape Hebrew University students travel to Korea to explore musical landscape
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group